Title |
Key Implementing Institution |
Geographical Area |
Research Field |
Dates of research |
Status |
|
Vulnerability Adaptation Assessments and Climate & Health Risk Profile development for Timor-Leste |
Ministry of Health, Timor-Leste |
Nationwide research
|
|
05-Oct-2023 Until 30-Apr-2024 |
Ongoing
|
|
Validation of the quantitative buffy coat test and evaluation of venous blood buffy coat specimens through nucleic acid-based amplification tests for the diagnosis of visceral and dermal leishmaniasis. |
Rajendra Memorial Research Institute of Medical Science (ICMR Regional Institute) |
India
|
Infectious Disease |
11-Mar-2025 Until 15-Dec-2025 |
Ongoing
|
|
Validation of direct detection nanopore sequencing-based method for identification of poliovirus in South-East Asia Region |
Self |
India, Indonesia, Thailand
|
Immunization/Vaccine Preventable Disease |
01-Nov-2024 Until 01-Nov-2026 |
Ongoing
|
|
Understanding the barriers and drivers to routine childhood vaccination in Forcibly Displaced Myanmar Nationals in Cox’s Bazar, Bangladesh |
Cox's Bazar Medical College |
Bangladesh
|
Immunization/Vaccine Preventable Disease |
01-Dec-2022 Until 31-May-2023 |
Ongoing
|
|
Tuberculosis Patient Cost Survey in Bangladesh |
Institute of Health Economics, University of Dhaka |
Nationwide research
|
Tuberculosis |
01-Jul-2023 Until 31-Dec-2023 |
Ongoing
|
|
To Study The Genetic Profile And Insecticide Susceptibility Of P. Argentipes The Vector Of Visceral Leishmaniasis In The State Of Bihar, India |
Rajendra Memorial Research Institute of Medical Science (ICMR Regional Institute) |
India
|
Infectious Disease |
17-Mar-2025 Until 15-Dec-2025 |
Ongoing
|
|
To develop and ascertain efficacy of Indian Neuropsychological continuum of healthcare model for stroke survivors and caregivers: A Randomized Control Trial |
All India Institute of Medical Sciences, New Delhi |
India
|
Non-communicable Disease |
01-Nov-2022 Until 30-Nov-2023 |
Completed
Download Final Report
|
|
Therapeutic Efficacy Study (TES) for three antimalarial drugs (Dihydroartemisinin-Piperaquine/DHA-PPQ, Artesunate-Pyronaridine/ASPY, Artemether-Lumefantrine/AL) in Keerom and Yapen Regencies, Papua, Indonesia |
Department Parasitology, Faculty of Medicine, Hasanuddin University |
Indonesia
|
Malaria |
15-Nov-2024 Until 31-Oct-2025 |
Ongoing
|
|
Therapeutic Efficacy Study (TES) for first line of anti-malaria drug (Dihydroartemisinin Piperaquine/DHA-PPQ) at Kupang and West Sumba districts of NTT province, Indonesia |
Department Parasitology, Faculty of Medicine, Hasanuddin University |
Indonesia
|
Malaria |
21-Nov-2022 Until 20-Jul-2023 |
Ongoing
|
|
The Knowledge and Tool Development for Depressive Symptoms Screening in Thai Elderly from Passive Sensing Data of Smartphones or Smartwatches |
International Health Policy Program |
Nationwide research
|
|
01-Nov-2022 Until 31-Oct-2023 |
Completed
Download Final Report
|
|
1 - 10 of 85 Items |
1 2 3 4 5 6 7 8 9 > >> |